| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Aneurysm | 25 | 2020 | 158 | 2.760 |
Why?
|
| Subarachnoid Hemorrhage | 42 | 2020 | 137 | 2.210 |
Why?
|
| Vasospasm, Intracranial | 3 | 2020 | 36 | 1.520 |
Why?
|
| Ischemic Attack, Transient | 41 | 1998 | 181 | 1.250 |
Why?
|
| Aneurysm, Ruptured | 9 | 2004 | 51 | 1.130 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 213 | 0.980 |
Why?
|
| Cerebral Infarction | 2 | 2020 | 71 | 0.750 |
Why?
|
| Cerebral Angiography | 26 | 2004 | 196 | 0.720 |
Why?
|
| Neurosurgery | 2 | 2011 | 84 | 0.530 |
Why?
|
| Hemoglobins | 7 | 2001 | 179 | 0.530 |
Why?
|
| Muscle, Smooth, Vascular | 17 | 2001 | 231 | 0.480 |
Why?
|
| Cerebral Arteries | 21 | 2001 | 74 | 0.460 |
Why?
|
| Aneurysm | 2 | 2003 | 58 | 0.430 |
Why?
|
| Basilar Artery | 10 | 2001 | 41 | 0.380 |
Why?
|
| Cerebral Veins | 1 | 2010 | 30 | 0.380 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 151 | 0.360 |
Why?
|
| Vascular Diseases | 1 | 2010 | 121 | 0.350 |
Why?
|
| Calcium | 10 | 2001 | 1156 | 0.350 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 262 | 0.320 |
Why?
|
| Endothelium, Vascular | 7 | 2001 | 435 | 0.300 |
Why?
|
| Oxyhemoglobins | 11 | 1994 | 31 | 0.290 |
Why?
|
| Tissue Plasminogen Activator | 9 | 1995 | 162 | 0.280 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1998 | 104 | 0.250 |
Why?
|
| Macaca fascicularis | 30 | 1999 | 108 | 0.210 |
Why?
|
| Subarachnoid Space | 2 | 2020 | 17 | 0.200 |
Why?
|
| Cerebral Hemorrhage | 6 | 1999 | 325 | 0.200 |
Why?
|
| Peroxides | 1 | 2001 | 12 | 0.200 |
Why?
|
| Humans | 42 | 2020 | 86643 | 0.200 |
Why?
|
| Phosphatidylcholines | 1 | 2001 | 48 | 0.190 |
Why?
|
| Cyclic GMP | 1 | 2001 | 58 | 0.190 |
Why?
|
| Endothelin-1 | 1 | 2001 | 41 | 0.190 |
Why?
|
| Multimedia | 1 | 2000 | 9 | 0.190 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 213 | 0.180 |
Why?
|
| Nitric Oxide | 2 | 2001 | 278 | 0.180 |
Why?
|
| Animals | 55 | 2020 | 26582 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2003 | 2601 | 0.170 |
Why?
|
| Primates | 1 | 2020 | 151 | 0.170 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 1999 | 104 | 0.170 |
Why?
|
| Monitoring, Intraoperative | 1 | 1999 | 109 | 0.170 |
Why?
|
| Vasoconstriction | 8 | 1999 | 93 | 0.160 |
Why?
|
| Pregnatrienes | 5 | 1998 | 14 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2000 | 814 | 0.140 |
Why?
|
| Canada | 2 | 2011 | 204 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2020 | 7993 | 0.130 |
Why?
|
| Free Radicals | 2 | 1994 | 73 | 0.130 |
Why?
|
| Smoking | 1 | 1998 | 609 | 0.120 |
Why?
|
| Dogs | 13 | 2001 | 685 | 0.120 |
Why?
|
| Female | 43 | 2003 | 44532 | 0.120 |
Why?
|
| Cerebral Ventricles | 1 | 1993 | 76 | 0.110 |
Why?
|
| Endothelins | 3 | 2001 | 35 | 0.110 |
Why?
|
| Erythrocytes | 3 | 1998 | 255 | 0.110 |
Why?
|
| Risk | 2 | 2004 | 674 | 0.110 |
Why?
|
| Middle Aged | 19 | 2004 | 25028 | 0.110 |
Why?
|
| Male | 26 | 2003 | 40965 | 0.100 |
Why?
|
| Craniotomy | 4 | 2003 | 88 | 0.100 |
Why?
|
| Vasodilation | 4 | 2001 | 96 | 0.100 |
Why?
|
| Cells, Cultured | 8 | 2001 | 2818 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2011 | 59 | 0.100 |
Why?
|
| Time Factors | 13 | 2004 | 5210 | 0.100 |
Why?
|
| Heparin | 2 | 2003 | 175 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2011 | 175 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 312 | 0.090 |
Why?
|
| Intracranial Embolism and Thrombosis | 2 | 2003 | 14 | 0.090 |
Why?
|
| Disease Models, Animal | 9 | 1992 | 2232 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2010 | 249 | 0.090 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 117 | 0.090 |
Why?
|
| Adult | 19 | 2003 | 25648 | 0.090 |
Why?
|
| Hemolysis | 3 | 1999 | 61 | 0.090 |
Why?
|
| Postoperative Complications | 9 | 2000 | 2207 | 0.080 |
Why?
|
| Aged | 13 | 2004 | 18415 | 0.080 |
Why?
|
| Cattle | 5 | 2001 | 376 | 0.080 |
Why?
|
| Lipid Peroxides | 3 | 1995 | 11 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2003 | 408 | 0.080 |
Why?
|
| Risk Factors | 4 | 2002 | 5417 | 0.080 |
Why?
|
| Recombinant Proteins | 7 | 1995 | 1014 | 0.070 |
Why?
|
| Brain | 3 | 2010 | 2216 | 0.070 |
Why?
|
| Prognosis | 4 | 2002 | 3679 | 0.070 |
Why?
|
| Blood Physiological Phenomena | 3 | 1994 | 9 | 0.070 |
Why?
|
| Lumbar Vertebrae | 2 | 1990 | 148 | 0.070 |
Why?
|
| Methemoglobin | 4 | 1993 | 8 | 0.060 |
Why?
|
| Hematoma, Subdural | 2 | 1983 | 23 | 0.060 |
Why?
|
| Adolescent | 7 | 2002 | 8981 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2004 | 80 | 0.060 |
Why?
|
| Adenosine Triphosphate | 3 | 2001 | 314 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2001 | 1961 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 4 | 1999 | 212 | 0.060 |
Why?
|
| Rupture, Spontaneous | 6 | 1992 | 43 | 0.060 |
Why?
|
| Antioxidants | 2 | 1998 | 223 | 0.060 |
Why?
|
| Analysis of Variance | 4 | 1999 | 912 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2003 | 8489 | 0.060 |
Why?
|
| Body Weights and Measures | 1 | 2003 | 27 | 0.060 |
Why?
|
| Free Radical Scavengers | 2 | 1995 | 59 | 0.060 |
Why?
|
| United States | 3 | 2002 | 6672 | 0.060 |
Why?
|
| Dalteparin | 1 | 2003 | 4 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2001 | 181 | 0.060 |
Why?
|
| Suction | 1 | 1983 | 35 | 0.060 |
Why?
|
| Fibrinolytic Agents | 3 | 1990 | 202 | 0.060 |
Why?
|
| Hematoma | 3 | 1991 | 104 | 0.060 |
Why?
|
| Angiography | 1 | 2003 | 208 | 0.060 |
Why?
|
| Seizures | 2 | 2003 | 297 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2002 | 6509 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2003 | 293 | 0.050 |
Why?
|
| Prospective Studies | 4 | 1999 | 4213 | 0.050 |
Why?
|
| Drainage | 1 | 1983 | 157 | 0.050 |
Why?
|
| Malondialdehyde | 4 | 1998 | 27 | 0.050 |
Why?
|
| Nitroarginine | 1 | 2001 | 16 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2001 | 36 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2001 | 90 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2004 | 1169 | 0.050 |
Why?
|
| Superoxide Dismutase | 2 | 1992 | 177 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2001 | 56 | 0.050 |
Why?
|
| Intraoperative Complications | 2 | 1999 | 185 | 0.050 |
Why?
|
| Bilirubin | 2 | 1991 | 125 | 0.050 |
Why?
|
| Nimodipine | 4 | 1988 | 11 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2001 | 1981 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 68 | 0.050 |
Why?
|
| Syringomyelia | 1 | 2000 | 15 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2001 | 143 | 0.050 |
Why?
|
| Pregnancy | 3 | 1999 | 2894 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 1998 | 364 | 0.050 |
Why?
|
| In Vitro Techniques | 9 | 2001 | 989 | 0.050 |
Why?
|
| Dura Mater | 1 | 2000 | 44 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 262 | 0.050 |
Why?
|
| Guanylate Cyclase | 2 | 2001 | 18 | 0.050 |
Why?
|
| DNA Primers | 1 | 2001 | 543 | 0.050 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2000 | 43 | 0.040 |
Why?
|
| Injections, Spinal | 8 | 1993 | 44 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2000 | 87 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1999 | 63 | 0.040 |
Why?
|
| Rats | 10 | 1999 | 3990 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1999 | 17 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2002 | 3640 | 0.040 |
Why?
|
| Brain Edema | 1 | 1999 | 50 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 1998 | 28 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 1998 | 1204 | 0.040 |
Why?
|
| Teratogens | 1 | 1998 | 13 | 0.040 |
Why?
|
| Thromboembolism | 1 | 1999 | 119 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 1978 | 50 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2003 | 2379 | 0.040 |
Why?
|
| Radiography | 4 | 1997 | 813 | 0.040 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1997 | 15 | 0.040 |
Why?
|
| Disease Progression | 1 | 2002 | 1531 | 0.040 |
Why?
|
| Serotonin | 5 | 1999 | 218 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 1998 | 112 | 0.040 |
Why?
|
| Prenatal Care | 1 | 1998 | 72 | 0.040 |
Why?
|
| Europe | 1 | 1998 | 309 | 0.040 |
Why?
|
| Muscle Contraction | 5 | 2001 | 283 | 0.040 |
Why?
|
| Potassium Chloride | 4 | 2001 | 87 | 0.040 |
Why?
|
| Astrocytoma | 1 | 1997 | 82 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1997 | 90 | 0.040 |
Why?
|
| Incidence | 2 | 1999 | 1577 | 0.040 |
Why?
|
| Nucleotides | 1 | 1997 | 95 | 0.040 |
Why?
|
| Random Allocation | 6 | 1995 | 332 | 0.040 |
Why?
|
| Age Factors | 2 | 1998 | 1851 | 0.040 |
Why?
|
| Base Sequence | 1 | 2001 | 2330 | 0.040 |
Why?
|
| Tyrphostins | 1 | 1996 | 7 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 32 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2003 | 2767 | 0.040 |
Why?
|
| Algorithms | 1 | 2004 | 1830 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 1621 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 243 | 0.040 |
Why?
|
| Norepinephrine | 4 | 1999 | 167 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1998 | 340 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1995 | 43 | 0.030 |
Why?
|
| Glioblastoma | 1 | 1997 | 255 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 9 | 0.030 |
Why?
|
| Nicotinic Acids | 2 | 1986 | 8 | 0.030 |
Why?
|
| Sex Factors | 1 | 1998 | 1054 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1996 | 254 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1996 | 182 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1996 | 302 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 1673 | 0.030 |
Why?
|
| Intracranial Pressure | 3 | 1993 | 77 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2002 | 3362 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 1997 | 763 | 0.030 |
Why?
|
| Chronic Disease | 6 | 1990 | 971 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1998 | 1219 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2002 | 2261 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 371 | 0.030 |
Why?
|
| Muscle, Smooth | 3 | 1981 | 354 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1994 | 57 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1994 | 114 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1993 | 47 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 1993 | 19 | 0.030 |
Why?
|
| Adenosine | 1 | 1996 | 225 | 0.030 |
Why?
|
| Signal Transduction | 4 | 1997 | 3241 | 0.030 |
Why?
|
| Sulfonamides | 1 | 1995 | 300 | 0.030 |
Why?
|
| Arteries | 1 | 1994 | 176 | 0.030 |
Why?
|
| Dinoprost | 3 | 2001 | 26 | 0.030 |
Why?
|
| Double-Blind Method | 6 | 1995 | 1823 | 0.030 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1993 | 48 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 1992 | 24 | 0.030 |
Why?
|
| Decision Making | 1 | 1998 | 642 | 0.030 |
Why?
|
| Catalase | 1 | 1992 | 48 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2003 | 117 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1992 | 123 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1993 | 220 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 1991 | 44 | 0.020 |
Why?
|
| Facial Muscles | 1 | 1990 | 23 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 1992 | 223 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 1920 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1990 | 63 | 0.020 |
Why?
|
| Calcium Channel Blockers | 2 | 1998 | 203 | 0.020 |
Why?
|
| Reoperation | 1 | 1991 | 597 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 1968 | 25 | 0.020 |
Why?
|
| Skull | 1 | 1990 | 249 | 0.020 |
Why?
|
| Veins | 1 | 1968 | 94 | 0.020 |
Why?
|
| Recurrence | 3 | 1997 | 1139 | 0.020 |
Why?
|
| Neurocognitive Disorders | 1 | 1987 | 13 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 1987 | 26 | 0.020 |
Why?
|
| Suramin | 2 | 1997 | 27 | 0.020 |
Why?
|
| Endothelium | 2 | 1996 | 59 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 639 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1991 | 135 | 0.020 |
Why?
|
| Delayed-Action Preparations | 3 | 1992 | 116 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 1995 | 18 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1987 | 502 | 0.020 |
Why?
|
| Haplorhini | 4 | 1979 | 81 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1997 | 26 | 0.020 |
Why?
|
| Pertussis Toxin | 2 | 1997 | 31 | 0.020 |
Why?
|
| Parietal Bone | 1 | 1983 | 20 | 0.010 |
Why?
|
| Placebos | 2 | 1995 | 218 | 0.010 |
Why?
|
| Pressure | 1 | 2003 | 165 | 0.010 |
Why?
|
| Thrombin | 2 | 1993 | 61 | 0.010 |
Why?
|
| Intracranial Hemorrhages | 1 | 2003 | 120 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 2001 | 24 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 2001 | 64 | 0.010 |
Why?
|
| Quinoxalines | 1 | 2001 | 50 | 0.010 |
Why?
|
| Reference Values | 2 | 1993 | 674 | 0.010 |
Why?
|
| Oxadiazoles | 1 | 2001 | 46 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 1992 | 425 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1995 | 916 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 2000 | 27 | 0.010 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2000 | 25 | 0.010 |
Why?
|
| Laminectomy | 1 | 2000 | 27 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1992 | 503 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1980 | 32 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2000 | 118 | 0.010 |
Why?
|
| Brain Ischemia | 2 | 1988 | 398 | 0.010 |
Why?
|
| Calcimycin | 2 | 1989 | 33 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 1999 | 7 | 0.010 |
Why?
|
| Genes, fos | 1 | 1999 | 24 | 0.010 |
Why?
|
| Spasm | 1 | 1979 | 16 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1686 | 0.010 |
Why?
|
| Acetylcholine | 2 | 1989 | 176 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1999 | 82 | 0.010 |
Why?
|
| Hydroxybenzoates | 1 | 1998 | 6 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1998 | 15 | 0.010 |
Why?
|
| Arterioles | 1 | 1978 | 22 | 0.010 |
Why?
|
| Carotid Artery, Internal | 2 | 1995 | 69 | 0.010 |
Why?
|
| Nicardipine | 1 | 1998 | 7 | 0.010 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 1997 | 3 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1999 | 221 | 0.010 |
Why?
|
| Uridine Triphosphate | 1 | 1997 | 5 | 0.010 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 1997 | 4 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1998 | 34 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 280 | 0.010 |
Why?
|
| Purinergic Antagonists | 1 | 1997 | 1 | 0.010 |
Why?
|
| Receptors, Purinergic | 1 | 1997 | 7 | 0.010 |
Why?
|
| Pyridoxal Phosphate | 1 | 1997 | 13 | 0.010 |
Why?
|
| Fluorometry | 1 | 1997 | 30 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1978 | 68 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 280 | 0.010 |
Why?
|
| Blood Flow Velocity | 2 | 1995 | 197 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1998 | 69 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 879 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1999 | 397 | 0.010 |
Why?
|
| Genistein | 1 | 1996 | 16 | 0.010 |
Why?
|
| Isoflavones | 1 | 1996 | 13 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1999 | 695 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1998 | 396 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1996 | 55 | 0.010 |
Why?
|
| Potassium | 1 | 1998 | 281 | 0.010 |
Why?
|
| Carbon Dioxide | 2 | 1974 | 188 | 0.010 |
Why?
|
| Nitriles | 1 | 1996 | 149 | 0.010 |
Why?
|
| Purines | 1 | 1996 | 91 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1995 | 90 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 104 | 0.010 |
Why?
|
| Injections | 1 | 1995 | 109 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 859 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1995 | 1143 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1997 | 999 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 125 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1996 | 306 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1994 | 44 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1994 | 81 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1993 | 13 | 0.010 |
Why?
|
| Cause of Death | 1 | 1995 | 277 | 0.010 |
Why?
|
| Staurosporine | 1 | 1993 | 33 | 0.010 |
Why?
|
| Alkaloids | 1 | 1993 | 45 | 0.010 |
Why?
|
| Colforsin | 1 | 1993 | 74 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1106 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 256 | 0.010 |
Why?
|
| Survival Rate | 1 | 1997 | 1863 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1996 | 370 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2000 | 3612 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 782 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1974 | 97 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1993 | 270 | 0.010 |
Why?
|
| Tunica Intima | 1 | 1992 | 59 | 0.010 |
Why?
|
| Sepharose | 1 | 1992 | 14 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1992 | 121 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1992 | 34 | 0.010 |
Why?
|
| Gels | 1 | 1992 | 48 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1992 | 11 | 0.010 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1991 | 4 | 0.010 |
Why?
|
| Fibrosis | 1 | 1992 | 203 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1991 | 56 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 316 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1991 | 35 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 1991 | 127 | 0.010 |
Why?
|
| Microcirculation | 1 | 1990 | 106 | 0.010 |
Why?
|
| Receptors, Histamine H1 | 1 | 1989 | 8 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1989 | 22 | 0.010 |
Why?
|
| Histamine | 1 | 1989 | 126 | 0.010 |
Why?
|
| RNA | 1 | 1993 | 560 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1991 | 596 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1991 | 182 | 0.010 |
Why?
|
| Thimerosal | 1 | 1989 | 6 | 0.010 |
Why?
|
| Cerebral Ventriculography | 1 | 1968 | 8 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1989 | 32 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1988 | 35 | 0.010 |
Why?
|
| Child | 1 | 2000 | 6927 | 0.010 |
Why?
|
| Saponins | 1 | 1989 | 41 | 0.010 |
Why?
|
| Actins | 1 | 1992 | 451 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1989 | 220 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1988 | 91 | 0.010 |
Why?
|
| Antifibrinolytic Agents | 1 | 1988 | 30 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 315 | 0.000 |
Why?
|
| Rabbits | 2 | 1979 | 636 | 0.000 |
Why?
|
| Respiration | 1 | 1968 | 262 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 318 | 0.000 |
Why?
|
| Biopsy | 1 | 1989 | 1163 | 0.000 |
Why?
|
| Epilepsy | 1 | 1968 | 397 | 0.000 |
Why?
|
| Partial Pressure | 2 | 1974 | 50 | 0.000 |
Why?
|
| Melanoma | 1 | 1968 | 459 | 0.000 |
Why?
|
| Macaca | 2 | 1974 | 87 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1988 | 1801 | 0.000 |
Why?
|
| Infant | 1 | 1968 | 3046 | 0.000 |
Why?
|
| Gastric Fundus | 1 | 1981 | 7 | 0.000 |
Why?
|
| Electrocardiography | 2 | 1974 | 478 | 0.000 |
Why?
|
| Heart Rate | 2 | 1974 | 492 | 0.000 |
Why?
|
| Xenon Radioisotopes | 1 | 1979 | 10 | 0.000 |
Why?
|
| Cyproheptadine | 1 | 1979 | 9 | 0.000 |
Why?
|
| Specimen Handling | 1 | 1980 | 98 | 0.000 |
Why?
|
| Methysergide | 1 | 1979 | 6 | 0.000 |
Why?
|
| Tachyphylaxis | 1 | 1979 | 14 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1979 | 244 | 0.000 |
Why?
|
| Hypercapnia | 1 | 1974 | 43 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1974 | 102 | 0.000 |
Why?
|
| Neurologic Manifestations | 1 | 1973 | 11 | 0.000 |
Why?
|
| Xenon | 1 | 1973 | 7 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1974 | 493 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1973 | 187 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1973 | 709 | 0.000 |
Why?
|
| Papilledema | 1 | 1968 | 3 | 0.000 |
Why?
|
| Hemiplegia | 1 | 1968 | 15 | 0.000 |
Why?
|
| Hemianopsia | 1 | 1968 | 4 | 0.000 |
Why?
|
| Reflex, Abnormal | 1 | 1968 | 5 | 0.000 |
Why?
|
| Occipital Lobe | 1 | 1968 | 24 | 0.000 |
Why?
|
| Oxygen | 1 | 1973 | 726 | 0.000 |
Why?
|
| Sensation | 1 | 1968 | 45 | 0.000 |
Why?
|
| Parietal Lobe | 1 | 1968 | 117 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1968 | 1056 | 0.000 |
Why?
|